CN1425431A - Bone marrow recovery medicine - Google Patents
Bone marrow recovery medicine Download PDFInfo
- Publication number
- CN1425431A CN1425431A CN 02156772 CN02156772A CN1425431A CN 1425431 A CN1425431 A CN 1425431A CN 02156772 CN02156772 CN 02156772 CN 02156772 A CN02156772 A CN 02156772A CN 1425431 A CN1425431 A CN 1425431A
- Authority
- CN
- China
- Prior art keywords
- medicine
- bone marrow
- eupolyphaga
- select
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The bone marrow recovery medicine is one medicine for treating osteomyelitis. It has the functions of invigorating vital energy and blood, strengthening kidney Yang, promoting blood circulation to disperse blood clots, promoting healing, etc and it has high and fast curative effect and no any side effect, and can cure osteomyelitis radically.
Description
The present invention is a kind of myelitic produce effects novel drugs that cures mainly, specifically theoretical according to medical science medicine, in conjunction with modern actual, through years of researches, clinical experiment, select for use after the checking: Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, multiple medicine such as Cornu Cervi Pantotrichum 10g is formed, through selected, after an amount of allotment, adopt modern technology, form through scientific method is refining, do not contain any chemical synthetic drug, have: fill blood, invigorating kidney-YANG, blood circulation promoting and blood stasis dispelling, promote functions such as healing, and good effect, instant effect, treating both the principal and secondary aspects of a disease, taking convenience, without any side effects, through clinical verification for many years, evident in efficacy, real strange medicine for treatment osteomyelitis is subjected to the consistent favorable comment of extensive patients.
The medicine that the above-mentioned similar disease of a lot of treatments is also arranged in the market, good effect, instant effect, treating both the principal and secondary aspects of a disease, taking convenience are released in the requirement that does not still reach extensive patients, and produce effects novel drugs without any side effects is still that extensive patients presses for.
For achieving the above object, according to traditional medical theory, in conjunction with modern actual, through development for many years, clinical experiment, select for use after the checking: multiple medicine such as Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, Cornu Cervi Pantotrichum 10g is formed, through after selected, an amount of allotment, adopt modern technology, make with extra care out a kind of novel drugs---Bone marrow recovery medicine with significant curative effect through scientific method.
Embodiment:
With what select for use: multiple medicine such as Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, Cornu Cervi Pantotrichum 10g is formed, and through after selected, an amount of allotment, adopts modern technology, makes with extra care through processes such as scientific methods to form.
Claims (3)
1, Bone marrow recovery medicine is theoretical according to medical science medicine, in conjunction with modern actual, through years of researches, clinical experiment, select for use after the checking: multiple medicine such as Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, Cornu Cervi Pantotrichum 10g is formed, through after selected, an amount of allotment, adopt modern technology, through the refining produce effects novel drugs that forms of processes such as scientific method.
2, described in claims 1, select for use: multiple medicines such as Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, Cornu Cervi Pantotrichum 10g are compositing formulas of the present invention.
3, described in claims 1, select for use: Radix Astragali 15g, Radix Angelicae Sinensis 10g, Herba Epimedii 10g, eupolyphaga 10g, Cornu Cervi Pantotrichum 10g etc. are medicine dosages of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02156772 CN1425431A (en) | 2002-12-18 | 2002-12-18 | Bone marrow recovery medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02156772 CN1425431A (en) | 2002-12-18 | 2002-12-18 | Bone marrow recovery medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1425431A true CN1425431A (en) | 2003-06-25 |
Family
ID=4752818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02156772 Pending CN1425431A (en) | 2002-12-18 | 2002-12-18 | Bone marrow recovery medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1425431A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550380A (en) * | 2013-11-15 | 2014-02-05 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
-
2002
- 2002-12-18 CN CN 02156772 patent/CN1425431A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550380A (en) * | 2013-11-15 | 2014-02-05 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
| CN103550380B (en) * | 2013-11-15 | 2015-07-08 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068661A (en) | Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea | |
| CN100336527C (en) | Medicine for treating celevical vertebra disease | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN101491653B (en) | Traditional Chinese medicine composite for treating rosacea and use method thereof | |
| CN102008562A (en) | External plaster for treating scapulohumeral periarthritis | |
| CN101983717A (en) | Traditional Chinese medicine for treating migraine | |
| CN101961434A (en) | Rheumatic Xintong powder | |
| CN1425431A (en) | Bone marrow recovery medicine | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN1390568A (en) | Capsule fr promoting blood circulation and removing obstruction in channel | |
| CN102657824A (en) | Medicine used for treating fracture | |
| CN1060073C (en) | Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process | |
| CN101856467A (en) | Chinese medicament for treating bone fractures | |
| CN1312111A (en) | Bone activating pill | |
| CN1299658A (en) | Medicine powder for eliminating tumor and cancer | |
| CN102526685A (en) | Medicament for treating cervical spondylosis | |
| CN1236806C (en) | Liver-tonifying stone-removing Chinese medicine | |
| CN1279958A (en) | Medicine for curing osteomyelitis and its preparing method | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN105663832A (en) | Traditional Chinese medicine composition for treating radiodermatitis | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN1425432A (en) | Urinary protein recovery pill | |
| CN1377669A (en) | Recovering medicine for lumbar vertebra | |
| CN1343502A (en) | Ulcer medicine for treating subcutaneous ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |